XML 51 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Basis of Presentation - Narrative (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jul. 27, 2021
Jun. 23, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 02, 2021
Dec. 31, 2020
Organization, Consolidation And Presentation Of Financial Statements [Line Items]                    
Working Capital Deficiency     $ 1,200,000       $ 1,200,000      
Deferred revenue     4,097,365       4,097,365     $ 4,603,270
Total Stockholders' Deficit     (12,536,419)       (12,536,419)     (14,608,186)
Net income (loss)     (349,684) $ 425,248 $ 406,558 $ (719,840) 75,564 $ (313,282)    
Net cash used in operating activities             (345,285) (675,103)    
Cash and cash equivalents     3,741,600       3,741,600     1,920,656
Cash Period Change             1,800,000      
Stock Issued During Period, Value, New Issues     2,737,770              
Shares Issued, Price Per Share   $ 4.10                
Proceeds from public offering, net of underwriting discounts paid             3,095,203 0    
Repayments of Short-term Debt     1,334,058       1,334,058 $ 0    
Series A redeemable convertible preferred stock, redemption value     $ 13,906,673       $ 13,906,673     $ 13,346,577
Subsequent Event                    
Organization, Consolidation And Presentation Of Financial Statements [Line Items]                    
Stock Issued During Period, Shares, New Issues 285,000                  
Shares Issued, Price Per Share $ 4.10                  
Proceeds from public offering, net of underwriting discounts paid $ 900,000                  
Common Stock                    
Organization, Consolidation And Presentation Of Financial Statements [Line Items]                    
Stock Issued During Period, Shares, New Issues   811,750 811,750              
Stock Issued During Period, Value, New Issues     $ 812              
Common Stock | Over-Allotment                    
Organization, Consolidation And Presentation Of Financial Statements [Line Items]                    
Stock Issued During Period, Shares, New Issues   86,750                
Amended and Restated Loan Agreement                    
Organization, Consolidation And Presentation Of Financial Statements [Line Items]                    
Notes payable                 $ 3,500,000  
Amended and Restated Loan Agreement | HCP-FVA, LLC                    
Organization, Consolidation And Presentation Of Financial Statements [Line Items]                    
Notes payable                 $ 2,200,000